Medicine guide
ATRIPLA
As listed in the register: ATRIPLA 600 mg/200 mg/245 mg, comprimé pelliculé
600 mg + 200 mg · comprimé pelliculé
- Prescription only
- Active substance
- Éfavirenz + Emtricitabine + Ténofovir Disoproxil (Fumarate De)
- Made by
- GILEAD SCIENCES IRELAND UC (IRLANDE)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | GILEAD SCIENCES IRELAND UC (IRLANDE) |
|---|---|
| Active substance | Éfavirenz + Emtricitabine + Ténofovir Disoproxil (Fumarate De) |
| Strength | 600 mg + 200 mg |
| Form | comprimé pelliculé |
| Route | orale |
| Dispensing (as stated by the register) | prescription initiale hospitalière annuelle · liste I · renouvellement non restreint |
| Marketed | No — authorised but not currently marketed, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/07/430 |
| Name in the register | ATRIPLA 600 mg/200 mg/245 mg, comprimé pelliculé |
| Packs | flacon(s) polyéthylène haute densité (PEHD) de 30 comprimé(s) avec fermeture de sécurité enfant |
| CIS | 64005832 |
| CIP13 | 3400938306996 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).